← Back to catalogue

Strobolux Iii Led

EUDAMEDFDA UDI

Class I (EU MDR)

Ref 28503822

by Optomic España S.a

Identity

Trade Name
STROBOLUX III LED EUDAMED
Optomic FDA UDI
Generic Name
Laryngostroboscope FDA UDI
Device Name
Stroboscope EUDAMED
Model / Reference
28503822 EUDAMED
Strobolux III LED Stroboscope FDA UDI

Identifiers

Primary DI / UDI-DI
08436041580256 EUDAMEDFDA UDI
Basic UDI-DI
84360415807203A EUDAMED
FDA Product Code
EQL FDA UDI
EMDN Code
Z12021010 LARYNGOSTROBOSCOPES EUDAMED
GMDN Term
Laryngostroboscope FDA UDI

Classification

Device Class
Class I EUDAMEDFDA UDI
Regulation Number
874.4750 FDA UDI
Market of Registration
Spain EUDAMED
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Strobolux Iii Led by Optomic España S.a — Class I — MDR, FDA UDI — listed in EUDAMED, FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

CE/MDR

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Optomic España S.a
EUDAMED SRN
ES-MF-000003235

Sources (2)

  • EUDAMED f0f68860-ec85-460a-8c45-b2118ec10e5b 61 fields · synced Jul 13, 2026
  • FDA UDI 7c4d95cc-f709-4894-b8b1-38bedb2a7f01 32 fields · synced May 30, 2026